http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Jun 2026 06:50:45 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html JPMorgan analyst Naoko Saito raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY1,900.00 (from JPY1,700.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html Mon, 22 Jun 2026 06:50:45 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html JPMorgan analyst Naoko Saito raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY1,900.00 (from JPY1,700.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html Mon, 22 Jun 2026 06:50:45 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html JPMorgan analyst Naoko Saito raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY1,900.00 (from JPY1,700.00) while maintaining a Overweight rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html Mon, 22 Jun 2026 06:50:45 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html JPMorgan analyst Naoko Saito raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY1,900.00 (from JPY1,700.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26669605.html Mon, 22 Jun 2026 06:50:45 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Downgrades/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html <p>Goldman Sachs analyst Akinori Ueda downgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Buy to Neutral with a price target of JPY2,050.00.</p><p>The analyst comments: “With the recent outperformance in the company's shares (+17% since end-March, vs. a 10% average decline in our Pharmaceuticals/Healthcare coverage over the same period), we believe the stock's relative undervaluation within the sector has diminished (our 12m target price implies 20% upside vs. an average of 19% for our Pharmaceuticals/Healthcare sector coverage, excluding SMID biotech PeptiDream). With this, we downgrade the shares to Neutral from Buy.</p><p>Following the release of FY3/26 earnings and FY3/27 guidance (link), we believe http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Downgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Neutral/26649335.html Tue, 16 Jun 2026 00:01:11 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Citi analyst Masahiro Shibano lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,200.00 (from JPY2,300.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Tue, 02 Jun 2026 05:58:11 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Citi analyst Masahiro Shibano lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,200.00 (from JPY2,300.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Tue, 02 Jun 2026 05:58:11 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Citi analyst Masahiro Shibano lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,200.00 (from JPY2,300.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Tue, 02 Jun 2026 05:58:11 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Citi analyst Masahiro Shibano lowered the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,200.00 (from JPY2,300.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Lowered+to+JPY2%2C200+at+Citi/26586346.html Tue, 02 Jun 2026 05:58:11 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Nomura/Instinet analyst Takahiro Mori raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,300.00 (from JPY2,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Thu, 21 May 2026 06:41:56 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Nomura/Instinet analyst Takahiro Mori raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,300.00 (from JPY2,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Thu, 21 May 2026 06:41:56 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Nomura/Instinet analyst Takahiro Mori raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,300.00 (from JPY2,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Intl+Ratings/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Thu, 21 May 2026 06:41:56 -0400 OCPNY http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Nomura/Instinet analyst Takahiro Mori raised the price target on Olympus Corporation (7733:JP) (OTC: OCPNY) to JPY2,300.00 (from JPY2,000.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+PT+Raised+to+JPY2%2C300+at+NomuraInstinet/26531143.html Thu, 21 May 2026 06:41:56 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Intl+Ratings/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html <p>Jefferies analyst Masahiro Nakanomyo upgraded Olympus Corporation (7733:JP) (OTC: OCPNY) from Hold to Buy with a price target of JPY2,300.00 (from JPY1,700.00).</p><p>The analyst comments "We raise our estimates and price target on Olympus, supported by an improved view on execution under new leadership. The new management team, led by Bob White, marks a clear break from the company’s historically insular leadership structure. Unlike prior CEOs, this is the first team with genuinely external medtech operating experience, bringing greater credibility to ongoing operational and regulatory remediation. As a result, we upgrade the stock to Buy."</p> http://www.streetinsider.com/Analyst+Comments/Jefferies+Upgrades+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29+to+Buy/26511389.html Mon, 18 May 2026 09:26:41 -0400 OCPNY http://www.streetinsider.com/Intl+Ratings/Macquarie+Reiterates+Neutral+Rating+on+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29/26481327.html <p>Macquarie analyst Tony Re reiterated a Neutral rating and JPY1,600.00 price target on Olympus Corporation (7733:JP) (OTC: OCPNY).</p> http://www.streetinsider.com/Intl+Ratings/Macquarie+Reiterates+Neutral+Rating+on+Olympus+Corporation+%287733%3AJP%29+%28OCPNY%29/26481327.html Wed, 13 May 2026 06:51:30 -0400 OCPNY